Publication:
Gut hormones and gut microbiota: implications for kidney function and hypertension

dc.contributor.coauthorAfşar, Barış
dc.contributor.coauthorVaziri, Nosratola D.
dc.contributor.departmentN/A
dc.contributor.kuauthorAslan, Gamze
dc.contributor.kuauthorTarım, Kayhan
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileResearcher
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokidN/A
dc.contributor.yokid327605
dc.contributor.yokid110580
dc.date.accessioned2024-11-09T22:52:50Z
dc.date.issued2016
dc.description.abstractIncreased blood pressure (BP) and chronic kidney disease are two leading risk factors for cardiovascular disease. Increased sodium intake is one of the most important risk factors for development of hypertension. Recent data have shown that gut influences kidney function and BP by variety of mechanisms. Various hormones and peptides secreted from gut such as gastrin, glucocorticoids, Glucagon-like peptide-1 impact on kidney function and BP especially influencing sodium absorption from gut. These findings stimulate scientist to find new therapeutic options such as tenapanor for treatment of hypertension by blocking sodium absorption from gut. The gastrointestinal tract is also occupied by a huge community of microbes (micro-biome) that under normal condition has a symbiotic relationship with the host. Alterations in the structure and function of the gut microbiota have been shown to play a key role in the pathogenesis and complications of numerous diseases including hypertension. Based on these data, in this review, we provide a summary of the available data on the role of gut and gut microbiota in regulation of BP and kidney function. (C) 2016 American Society of Hypertension. All rights reserved.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.volume10
dc.identifier.doi10.1016/j.jash.2016.10.007
dc.identifier.eissn1878-7436
dc.identifier.issn1933-1711
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85006132466
dc.identifier.urihttp://dx.doi.org/10.1016/j.jash.2016.10.007
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7069
dc.identifier.wos390293000008
dc.keywordsIntestinal hormones
dc.keywordsKidney disease
dc.keywordsMicrobiota
dc.keywordsNa plus /H plus exchanger-3 glucagon-like peptide-1
dc.keywordsBlood-pressure
dc.keywordsPharmacological inhibition
dc.keywordsDietary-sodium
dc.keywordsSalt intake
dc.keywordsReceptor
dc.keywordsAbsorption
dc.keywordsNHE3
dc.keywordsImprovement
dc.keywordsExpression
dc.languageEnglish
dc.publisherElsevier Science Inc
dc.sourceJournal of The American Society of Hypertension
dc.subjectPeripheral vascular disease
dc.titleGut hormones and gut microbiota: implications for kidney function and hypertension
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0003-4000-3292
local.contributor.authorid0000-0002-6071-1539
local.contributor.authorid0000-0002-1297-0675
local.contributor.kuauthorAslan, Gamze
local.contributor.kuauthorTarım, Kayhan
local.contributor.kuauthorKanbay, Mehmet

Files